| |
| |
|
| Insider
Information: |
Truitt Joseph |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,750 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,163 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,750 |
|
|
| Total
Value |
$3,163 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Achillion Pharmaceuticals Inc |
ACHN |
|
2020-01-28 |
0 |
2014-06-09 |
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director |
2023-05-17 |
2,750 |
2023-05-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2023-05-17 |
4 |
B |
$3.73 |
$10,258 |
D/D |
2,750 |
2,750 |
2.39 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-01-28 |
4 |
D |
$6.30 |
$22,050 |
D/D |
(3,500) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-10-16 |
4 |
S |
$6.37 |
$850,947 |
D/D |
(133,484) |
3,500 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-10-16 |
4 |
OE |
$3.10 |
$419,785 |
D/D |
133,484 |
136,984 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Commercial Officer |
• – – |
2016-12-02 |
4 |
B |
$4.06 |
$14,210 |
D/D |
3,500 |
3,500 |
2.74 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-08-25 |
4 |
S |
$10.82 |
$270,500 |
D/D |
(25,000) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-08-25 |
4 |
OE |
$0.82 |
$20,500 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-06-16 |
4 |
S |
$7.82 |
$195,500 |
D/D |
(25,000) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-06-16 |
4 |
OE |
$0.82 |
$20,500 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-06-10 |
4 |
S |
$6.05 |
$296,148 |
D/D |
(48,950) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-06-10 |
4 |
OE |
$0.82 |
$40,139 |
D/D |
48,950 |
48,950 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-06-09 |
4 |
S |
$4.82 |
$5,061 |
D/D |
(1,050) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP, Chief Commercial Officer |
• – – |
2014-06-09 |
4 |
OE |
$0.82 |
$861 |
D/D |
1,050 |
1,050 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
